Some U.S. politicians clearly got real shots. Fetterman had his stroke, as did that New Mexico senator. A congressman's teenage daughter died. Newsom had GBS. I'm sure there's more injury examples.
Some U.S. politicians clearly got real shots. Fetterman had his stroke, as did that New Mexico senator. A congressman's teenage daughter died. Newsom had GBS. I'm sure there's more injury examples.
Hedley Rees, a pharma quality expert has a great substack titled "Inside Pharma" that addresses the quality issues associated with the shots. There is a good chance that the shots vary from batch to batch and dose to dose for multiple reasons. This variability adds to the biological uncertainties associated with reactions.
The bottom line is that until the manufacturing process undergoes a quality certification, the product cannot be considered licensed, so the bio-equivalency statement that the pharma companies are floating to substitute the EUA products for the Licensed versions is a deceptive play. There are no licensed vaccines available in the U.S. yet you can't turn on a TV or radio station without hearing a vax ad. Pharma companies are not allowed to market EUA products and they are getting around this by marketing a licensed product and inducing product substitution at the point of sale/administration. I'm no lawyer, but it seems like this area is ripe for lawsuits.
Some U.S. politicians clearly got real shots. Fetterman had his stroke, as did that New Mexico senator. A congressman's teenage daughter died. Newsom had GBS. I'm sure there's more injury examples.
Hedley Rees, a pharma quality expert has a great substack titled "Inside Pharma" that addresses the quality issues associated with the shots. There is a good chance that the shots vary from batch to batch and dose to dose for multiple reasons. This variability adds to the biological uncertainties associated with reactions.
Here is a link to his substack - https://hedleyrees.substack.com/
The bottom line is that until the manufacturing process undergoes a quality certification, the product cannot be considered licensed, so the bio-equivalency statement that the pharma companies are floating to substitute the EUA products for the Licensed versions is a deceptive play. There are no licensed vaccines available in the U.S. yet you can't turn on a TV or radio station without hearing a vax ad. Pharma companies are not allowed to market EUA products and they are getting around this by marketing a licensed product and inducing product substitution at the point of sale/administration. I'm no lawyer, but it seems like this area is ripe for lawsuits.